# "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects

> **NCT00114933** · PHASE4 · COMPLETED · sponsor: **Arribas, Jose R., M.D.** · enrollment: 200 (—)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Stopping nucleosides and continuing lopinavir/ritonavir monotherapy

## Key facts

- **NCT ID:** NCT00114933
- **Lead sponsor:** Arribas, Jose R., M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 200 (—)
- **Last updated:** 2008-03-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00114933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00114933, ""OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00114933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*